相关实验视频

Updated: Jul 19, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

利古斯提利德与HMGCS1的Cys129共同结合,以改善脱脂症

Kaixue Zhang¹, Fukui Shen¹, Wei Lei²

¹State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, PR China.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|August 14, 2023

概括

利古斯提利德通过抑制胆固醇合成来缓解脱脂症. 它针对HMGCS1,为脂质代谢障碍提供了一种新的治疗方法.

科学领域:

生物化学生化学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

脱脂症,标志着高胆固醇和甘油三,是心血管疾病的主要危险因素.
现有的降脂药物具有局限性,因此需要新的治疗策略.
自然化合物ligustilide (Lig) 在调节脂质代谢方面表现出潜力,但其机制尚未完全理解.

研究的目的:

阐明利古斯提利德在缓解脱脂症时的作用机制.
为了确定参与脂质代谢的Ligustilide的特定分子标.
探索Ligustilide作为一种潜在的治疗药物治疗失脂症.

主要方法:

动物高脂肪饮食诱导的脂质不良症模型.
化学生物分析以确定标蛋白质.
酶抑制测定和结合研究.
涉及分子相互作用的机制研究.

主要成果:

利古斯提利德有效地缓解了高脂肪饮食引起的脂质不良症.
肝细胞中的3-基-3-甲基氨酸辅酶A合成酶1 (HMGCS1) 被确定为标蛋白.
利古斯提利德不可逆转地与HMGCS1的Cys129结合,抑制胆固醇生物合成.
观察到改善的脂质代谢障碍.

结论:

利古斯提利德通过通过HMGCS1.1抑制胆固醇合成来发挥其降脂作用.
对HMGCS1的不可逆转的结合为Ligustilide的作用提供了一个明确的分子机制.
利古斯提利德 (Ligustilide) 是一种有前途的新型结构化合物,用于治疗失脂血症.

关键词:

协同抑制剂协同抑制剂脱脂血症是什么意思脱脂血症是什么意思在HMGCS1中.利古斯蒂化物脂质代谢脂质代谢是一种

更多相关视频

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Lipid Catabolism

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...